The Effects of Adding Art Therapy to Ongoing Antidepressant Treatment in Moderate-to-Severe Major Depressive Disorder: A Randomized Controlled Study

Int J Environ Res Public Health. 2022 Dec 21;20(1):91. doi: 10.3390/ijerph20010091.

Abstract

This randomized controlled study aimed to investigate the effects of art psychotherapy on moderate-to-severe major depressive disorder (MDD). Forty-two MDD patients were recruited from a psychiatric outpatient clinic in Seoul, the Republic of Korea. Participants were allocated on a randomized, open-label basis to either an experimental group, wherein they were treated with art psychotherapy added to pharmacotherapy, or a control group, wherein they were treated with pharmacotherapy alone. Pre- and post-test measures of the Hamilton Depression Rating Scale, Beck Depression Inventory-II, and remission rates were measured. The results indicate that patients treated with art psychotherapy and ongoing pharmacotherapy showed slightly greater improvement when compared with pharmacotherapy alone in moderate-to-severe MDD. These results suggest that art psychotherapy could be an effective add-on strategy for the treatment of moderate-to-severe MDD. However, a rigorous test would facilitate a better understanding of art psychotherapy as an add-on strategy for MDD treatment.

Keywords: antidepressants; art psychotherapy; combined therapy; depression; major depressive disorder.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Art Therapy*
  • Combined Modality Therapy
  • Depressive Disorder, Major* / drug therapy
  • Depressive Disorder, Major* / psychology
  • Humans
  • Psychotherapy / methods
  • Research Design
  • Treatment Outcome

Substances

  • Antidepressive Agents

Grants and funding

This research received no external funding.